Regulatory & Drug Development Director

PhD Pharmacology. 30 years in drug development. Market authorization of 7 drugs in EU/US.

Investor Relations EU

Katja Görnemann is a certified EFFAS financial analyst specialized in Equity and Fixed Income Investor Relations (IR), Corporate Development, Corporate Finance and Corporate Communication. His professional development has focused on the preparation and execution of IPOs (Gestevisión Telecinco, Talgo), corporate bond issuances, as well as the design and implementation of IR strategic plans in multinational…

Dr. Jörg Landwehr

Licensing Director

PhD Molecular Biology. +20 years in Licensing, Business Analytics and Strategic Consulting at Roche, PharmaMar and ActeaVentures.

Maria Gonzalez


PhD in Biotechnology. In vivo / in vitro, diagnostic techniques, clinical data models and data quality specialist.

Guillermo Gentil


Degree in Economics. Experienced in financials. Former Associate Professor.

Diego Medina


MD. Physician. Master in Medical Management and Clinical Management.

Fran Guillen

General Manager

Engineer, serial entrepreneur, angel investor and director of a business accelerator. Senator at World Business Angels Forum.

Carmen Lara


Degree in Economics and Business and MBA. Experienced in managing several SMEs.

Vicente Salinas


MD/PhD Physician and Pathologist. +15 years in cancer research.